PBE

Invesco Biotechnology & Genome ETF
NYSEArcaUSDETF / FUND DELAYED
Last price
94.70
▼ 2.34 (2.41%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
97.04
Day high
95.61
Day low
94.27
Volume
8.05K
Market cap
—
P/E (TTM)
25.85
52W range
70.01 – 98.82

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-2.53% -4.5%
1M
-3.01% -4.2%
3M
+2.43% -2.1%
6M
+20.41% +2.2%
YTD
+15.28% +1.0%
1Y
+30.24% +13.8%
3Y
+66.02% -16.2%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
NTRA Natera Inc 6.23%
ILMN Illumina Inc 6.17%
BIIB Biogen Inc 5.19%
GILD Gilead Sciences Inc 5.08%
AMGN Amgen Inc 4.84%
VRTX Vertex Pharmaceuticals Inc 4.80%
RPRX Royalty Pharma PLC Class A 4.77%
REGN Regeneron Pharmaceuticals Inc 4.62%
MRNA Moderna Inc 3.36%
NVAX Novavax Inc 3.17%

Sector exposure

Fund weightings
Healthcare
100.00%

Fund profile

As reported
Fund familyInvesco
CategoryHealth
Legal typeExchange Traded Fund
Expense ratio0.59%
Turnover103.0%
Total net assets$17.80M

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on PBE open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E25.85
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
0.01
Call-heavy session
Put / call open interest
0.03
Positioning, not flow
Max pain
60.00
-36.6% from spot
ATM implied vol
0.2%
Nearest strike to spot
Skew (10% OTM)
+12.3%
Puts bid over calls
Call volume
75
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
87.00
50 contracts
Heaviest put OI
55.00
1 contracts

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
96.44
-1.81% from price
SMA 20
95.46
-0.80% from price
SMA 50
95.09
-0.41% from price
SMA 100
90.77
+4.32% from price
SMA 200
85.86
+10.30% from price
EMA 12
96.01
-1.37% from price
EMA 26
95.76
-1.11% from price
EMA 50
94.52
+0.18% from price
RSI (14)
46.1
Neutral
MACD (12,26,9)
0.26
Hist -0.17
ATR (14)
1.79
1.89% of price
Realised vol 30D
21.2%
Annualised
Bollinger upper
98.68
20, 2σ
Bollinger lower
92.25
20, 2σ
50 / 200 cross
Golden
95.09 vs 85.86
Trend bias
Above 200
+10.30%

Options chain

Account required
Expiry
Spot 94.70
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.62
Less volatile than market
Correlation to SPY
0.42
Loosely linked
Realised vol 30D
21.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-11.8%
Peak to trough
Max drawdown 5Y
-32.6%
Peak to trough
ATR 14
1.79
1.89% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.